Read the latest positive news, breakthroughs, and inspiring stories about ovarian cancer, curated daily by BrightWire.
A survivor's decade-long journey reveals how research has revolutionized ovarian cancer care, replacing grueling treatments with personalized therapies that extend life while improving quality. Her story shows why clinical trials matter.
When Becky Drexler lost her best friend to ovarian cancer in 2017, she channeled her grief into advocacy work that would later save her own life. Just months after her friend's death, new treatments emerged that turned a once-deadly diagnosis into a survivable one.
A nurse practitioner's instinct to order a CT scan instead of a colonoscopy caught Kate Ping's advanced ovarian cancer in time to treat it. That decision, inspired by the loss of the nurse's own friend, gave Ping a fighting chance against a disease that often goes undetected until too late.
Seven-time Olympic medalist Shannon Miller is sharing her powerful message of hope 13 years after beating ovarian cancer. The gymnastics legend wants patients to know that a positive mindset can transform their treatment journey.
A simple biomarker test is helping doctors identify which ovarian cancer patients can benefit from precision treatments that work like guided missiles against tumors. The breakthrough offers new hope especially for women whose cancer stopped responding to traditional chemotherapy.
A 58-year-old ovarian cancer patient in Manchester became the first person in the world to receive a pioneering therapy that could transform how we fight multiple types of cancer. The "off-the-shelf" treatment uses donated immune cells engineered to hunt down tumors.
Tracy Tomlinson became the world's first person to receive a groundbreaking cancer treatment that could make advanced therapies faster and cheaper for patients everywhere. The "off-the-shelf" approach uses donor immune cells engineered to hunt down cancer, a major shift from expensive personalized treatments.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
Scientists created a "smart" nanoparticle that targets ovarian cancer cells while leaving healthy tissue untouched. The breakthrough could make treatment safer and more effective for thousands of women.
The NHS just approved a groundbreaking ovarian cancer treatment that works like a guided missile, targeting only cancer cells while leaving healthy tissue untouched. For women with platinum-resistant ovarian cancer who had almost no options left, this precision medicine marks a genuine turning point.
Women with hard-to-treat ovarian cancer now have a breakthrough treatment that adds precious months to their lives while making them feel better. The targeted drug has been called the most significant advance in ovarian cancer care in over 20 years.
Hundreds of women with chemotherapy-resistant ovarian cancer in England now have access to a groundbreaking treatment that extends life and shrinks tumors. It's the first new option approved for this hard-to-treat cancer in two decades.